Skip to main content
SpringerLink
Log in

Blutersatzstoffe

  • Chapter
Transfusionsmedizin

  • 52 Accesses

Zusammenfassung

Unter Blutersatzstoffen im engeren Sinne werden Substanzen und Lösungen nicht-menschlichen Ursprungs verstanden, die geeignet sind, in bestimmten Krankheitssituationen die vitalen Funktionen des Blutes für eine bestimmte Zeit aufrecht zu erhalten. Zu ihnen gehören in erster Linie Elektrolytlösungen, die dem akuten Volumenersatz dienen, kolloidale wäßrige Systeme zur Aufrechterhaltung des kolloid-osmotischen Drucks und künstliche Sauerstoffträger für den Transport und Austausch der Atemgase.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agishi T, Sonda K, Nakajima I, Fuchinoue S, Honda H, Suga H, Liu H, Teraoka S, Ota K (1992) Modified hemoglobin solution as possible perfusate relevant to organ transplantation. Biomat Art Cells Immobiliz Biotechnol 20: 539–544

    CAS  Google Scholar 

  2. Agishi T, Funakoshi Y, Honda H, Yamagata K, Kobayashi M, Takahashi M (1988) Pyridoxylated hemoglobin-polyoxyethylene conjugate solution as blood substitute for normothermic whole body rinse-out. Biomat Art Cells Art Organs 16 (1–3): 261–270

    CAS  Google Scholar 

  3. Alayash AI (1994) Hemoglobin-based blood substitutes: potential free radical toxicity. Free Radic Biol Med 16 (1): 137–138

    Article  PubMed  CAS  Google Scholar 

  4. Anon (1990) 4th consensus conference on intensiv care and emergency medicine. Choice of vascular filling products for the treatment of hypovolemia in adults. Rev Prat 40 (8): 747–749

    Google Scholar 

  5. Bachir D, Galacteros F (1994) Potential alternatives to erythrocyte transfusion in hemoglobinopathies: hydroxyurea (HU), erythropoietin (EPO), butyrate derivatives, blood substitutes. Transfus Clin Biol 1: 35–39

    Article  PubMed  CAS  Google Scholar 

  6. Bakker JC, Berbers GA, Sleeker WK, den Boer PJ, Biessels PT (1992) Preparation and characterization of crosslinked and polymerized hemoglobin solutions. Biomat Art Cells Immobiliz Biotechnol 20: 233–241

    CAS  Google Scholar 

  7. Barnikol WK, Burkhard O, (1987) Huge compact soluble molecules: a new old concept to develop an oxygen carrying substitute. Biomat Art Cells Art Organs 15: 346–349

    Google Scholar 

  8. Beach MC, Morley J, Spiryda I, Weinstock SB (1988) Effects of liposome encapsulated hemoglobin on the reticuloendothelial system. J Biomat Art Cells Immobiliz Biotechnol 16: 635–636

    Google Scholar 

  9. Behan M, OÇonnel D, Mattrey RF, Carney DN (1991) Perfluorooctylbromide as a contrast agent for sonography and computed tomography. (1993) AJR. Am J Roentgenol 160: 399405

    Google Scholar 

  10. Billhardt RA, Rosenbush SW (1986) Cardiogenic and hypo volemic shock. Med Clin N Am 70 (4): 853–876

    PubMed  CAS  Google Scholar 

  11. Biro GP (1993) Perfluorcarbon-based red blood cell substitutes, Transfus Med Rev 7 (2): 84–95

    Article  PubMed  CAS  Google Scholar 

  12. Biro GP, Jing N, Anderson PJ (1992) Studies on blood substitutes based on hemoglobin and perfluorocarbon. Biomat Art Cells Art Organs 20 (2–4): 1013–1020

    CAS  Google Scholar 

  13. Biro GP (1988) Blood substitutes and the cardiovascular system. Biomat Art Cells Art Organs 16 (1–3): 595–606

    CAS  Google Scholar 

  14. Biro GP, Blais P (1987) Perfluorocarbon blood substitutes. Crit Rev Oncol Hematol 6: 311–374

    Article  PubMed  CAS  Google Scholar 

  15. Bornert P, Norris DG, Koch H, Dreher W, Reichelt H, Leibfritz D (1993) Fast perfluorcarbon imaging using 19F U-FLARE. Magn Reson Med 29 (2): 226–234

    Article  PubMed  CAS  Google Scholar 

  16. Branca D, Giron F, Conte L, Vincenti E, Scutari G (1989) Energetic behaviour of mitochondria isolated from rat livers perfused with a perfluorodecalin + N,N-perfluorodiethylcyclohexylamine emulsion. Biochem Pharmacol 38 (18): 3045–3048

    Article  PubMed  CAS  Google Scholar 

  17. Bruneton JN, Falewee MN, Francois E, Cambon P, Philip C, Riess JG, Balu Maestro C, Rogopoulos A (1989) Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide. Radiology 170: 179–183

    PubMed  CAS  Google Scholar 

  18. Bunn HF (1993) The use of hemoglobin as a blood substitute. Am J Hematol 42 (1): 112–117

    Article  PubMed  CAS  Google Scholar 

  19. Bunn HF, Jandl JH (1968) The renal handling of hemoglobin. Trans Assoc Am Phys 81: 147

    PubMed  CAS  Google Scholar 

  20. Byrne K, Tatum JL, Henry DA, Hirsch JI, Crossland M, Barnes T, Thompson JA, Young J, Sugerman HJ (1992) Increased morbidity with increased pulmonary albumin flux in sepsis-related adult respiratory distress syndrome. Crit Care Med 20: 28–34

    Article  PubMed  CAS  Google Scholar 

  21. Chang S, Reppucci V, Zimmerman NJ, Heinemann MH, Coleman DJ (1989) Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology 96: 785–791

    PubMed  CAS  Google Scholar 

  22. Chang TM (1992) Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview. Biomat Cells Immobiliz Biotechnol 20: 159–179

    CAS  Google Scholar 

  23. Chang TM, Farmer M, Geyer RP, Moss G (1987) Blood substitutes based on modified hemoglobin and fluorochemicals. ASAIO-Trans 33 (4): 819–823

    PubMed  CAS  Google Scholar 

  24. Clark LC, Gollan F (1966) Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152: 1755–1756

    Article  PubMed  CAS  Google Scholar 

  25. Cron TA, Gerber H (1991) Anaphylaktoide Reaktion auf Physiogel SRK 4–ein Beitrag zur Kontroverse Anaphylactoid reaction to Physiogel SRK 4% a contribution to the controversy about plasma substitutes. Schweiz Med Wochenschr 121 (48): 1773–1776

    PubMed  CAS  Google Scholar 

  26. Davies MJ (1989) Crystalloid or colloid: does it matter? J Clin Anesth 1 (6): 464–471

    Article  PubMed  CAS  Google Scholar 

  27. DeVenuto F, Zegna AI (1982) Blood exchange with pyridoxä-lated-polymerized hemoglobin. Sug Gynecol Obstet 155: 342 (1982)

    CAS  Google Scholar 

  28. DeVenuto F (1983) Modified hemoglobin solution as a resuscitation fluid. Vox Sang 44: 129–142

    Article  PubMed  CAS  Google Scholar 

  29. Doweiko JP, Nompleggi DJ (1991) The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. JPEN J Parenter Enterol Nutr 15: 476–483

    Article  CAS  Google Scholar 

  30. Draffehn J, Reichelt H (1991) Untersuchungen zur Toxizität oberflächenaktiver Substanzen zur Emulgierung von Perfluorcarbonverbindungen als Bestandteil von Blutersatzmitteln (The toxicity of surface-active substances for emulsifying perfluorocarbon compounds as components of blood substitute preparations). Pharmazie 46 (4): 271–272

    PubMed  CAS  Google Scholar 

  31. Draffehn J, Reichelt H, Sauer S (1991) Untersuchungen zur Einstellung des kolloidosmotischen Druckes von Blutersatzmitteln auf Perfluorcarbonbasis (The standardization of colloid osmotic pressure of blood substitutes with a perfluorocarbon base). Pharmazie 46 (7): 525–527

    PubMed  CAS  Google Scholar 

  32. Draffehn J, Reichelt H (1991) Untersuchungen zum rheologischen Verhalten von Blutersatzmitteln auf Perfluorcarbonbasis (Rheological behavior of blood substitutes with a perfluorcarbon basel). Pharmazie 46 (11): 800–802

    PubMed  CAS  Google Scholar 

  33. Edwards JD, Nightingale P, Wilkins RG, Faragher EB (1989) Hemodynamic and oxygen transport response to modified fluid gelatin in critically ill patients. Crit Care Med 17 (10): 996–998

    Article  PubMed  CAS  Google Scholar 

  34. Emerson TEJ (1989) Unique features of albumin: a brief review. Crit Care Med 17: 690–694

    Article  PubMed  Google Scholar 

  35. Faithfull NS (1987) Fluorocarbons. Current status and future applications. Anaesthesia 42: 234–242

    Article  PubMed  CAS  Google Scholar 

  36. Fronticelli C, Bucci E (1994) Conformational and functional characteristics of bovine hemoglobin. Meth Enzymol 231: 150–163

    Article  PubMed  CAS  Google Scholar 

  37. Fronticelli C, Brinigar W, Grycznski Z, Bucci E (1991) Engineering of low oxygen affinity hemoglobins. J Biomat Art Cells Immobiliz Biotechnol 19 (2): 385

    Google Scholar 

  38. Fuchinoue S, Takahashi K, Teraoka S, Toma H, Ashishi T, Ota K (1986) Clinical experience in kidney preservation with a new fluorocarbon emulsion perfusate. Transplant Proc 18: 566–570

    Google Scholar 

  39. Fuhrman BP, Paczan PR, DeFrancisis M (1991) Perfluorocarbon-associated gas exchange. Crit Care Med 19 (5): 712–722

    Article  PubMed  CAS  Google Scholar 

  40. Fuhrman BP (1990) Perfluorcarbon liquid ventilation: the first human trial (editorial; comment). J Pediatr 117 (1 pt 1): 106–111

    Google Scholar 

  41. George M, Griffith N, Lehot JJ, Durand PG, Estanove S (1993) Comparaison dextran 40 à3,5% versus albumine à 40/0 utilisés comme solutes d’expansion volémique après chirurgie cardiaque. Effets sur les paramètres hémodynamiques et la pression oncotique colloidale (A comparison of 3,5% dextran 4o and 66. 4% albumin used as volume expansion solutions following heart surgery. Effects on the hemodynamic parameters and the oncotic colloidal pressure). Cah Anesthesiol 41 (1): 18–22

    PubMed  CAS  Google Scholar 

  42. Geyer RP (1985) Surfactants and perfluorochemical emulsions for use in blood replacement preparations. Int Anesthesiol Clin 23 (1): 25–36

    Article  PubMed  CAS  Google Scholar 

  43. Geyer RP, Monroe RG, Taylor K (1968) Survival of rats totally 68. perfused with a fluorocarbon-detergent preparation. Organ Perfus Presery 85–96

    Google Scholar 

  44. Giesecke AH, Grande CM, Whitten CW (1990) Fluid therapy and the resuscitation of traumatic shock. Crit Care Clin 6 (1): 61–72

    PubMed  Google Scholar 

  45. Goldberg BB (1993) Ultrasound contrast agents. Clin Diagn Ultrasound 28: 35–45

    PubMed  CAS  Google Scholar 

  46. Gollan F, Clark LC (1966) Organ perfusion with fluorocarbon fluid. Physiologist 9: 191

    Google Scholar 

  47. Gould SA, Sehgal LR, Sehgal HL, Moss GS (1993) Hypovolemic shock. Crit Care Clin 9 (2): 239–259

    PubMed  CAS  Google Scholar 

  48. Gould SA, Sehgal LR, Sehgal HL, Moss GS (1992) Artificial blood: current status of hemoglobin solutions. Crit Care Clin 8: 293–309

    PubMed  CAS  Google Scholar 

  49. Gould SA, Rosen AL, Sehgal LR, Sehgal HL, Langdale LA, Krause LM, Rice CL, Chamberlin WH, Moss GS (1986) Fluo-sol-Da as a red-cell substitute in acute anemia. N Engl J 73. Med 314 (26): 1653–1656

    Article  CAS  Google Scholar 

  50. Grünert A, Qiu H, Muller I, Schuh S, Steinbach G, Wennauer R, Wolf C, Von Schenk H (1994) A new extracorporeal perfusion system: prolongation of liver organ vitality beyond 24 hours. Ann N Y Acad Sci 723: 488–490

    Article  PubMed  Google Scholar 

  51. Grünert A (1994) Künstliche Sauerstoffträger–Perfluorkarbone. Infusionsther Transfusionsmed 21 [Suppl 3]: 57–62

    PubMed  Google Scholar 

  52. Grünert A (1990) Biophysical fundamentals of nutrition. Klin Anasthesiol Intensivther 40: 110–122

    Article  PubMed  Google Scholar 

  53. Grünert A (1985) Onkometrie - Grundlagen, Meßtechnik and klinischer Einsatz des kolloidosmotischen Druckes. Kohlhammer, Stuttgart Berlin Köln Mainz

    Google Scholar 

  54. Grünert A, Hirlinger KH, Herrmann M, Petutschnigk D (1982) Experiences with Fluosol in animal experiments. In: Frey R, Beibarth H, Stosseck K (eds) Oxygen carrying colloidal blood substitutes. Zuckschwerdt, München

    Google Scholar 

  55. Gulati A, Rebello S (1994) Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 124: 125–133

    PubMed  CAS  Google Scholar 

  56. Guthrie RDJ, Hines CJ (1991) Use of intravenous albumin in the critically ill patient. Am J Gastroenterol 86: 255–263

    PubMed  Google Scholar 

  57. Haljamae H (1993) Volume substitution in shock. Acta Anaesthesiol Scand Suppl 98: 25–28

    Article  CAS  Google Scholar 

  58. Haupt MT, Kaufman BS, Carlson RW (1992) Fluid resuscitation in patients with increased vascular permeability. Crit Care Clin 8 (2): 341–353

    PubMed  CAS  Google Scholar 

  59. Haupt MT (1986) Colloidal and crystalloidal fluid resuscitation in shock associated with increased capillary permeability. Curr Stud Hematol Blood Transfus 53: 86–100

    PubMed  Google Scholar 

  60. Hong F, Shastri K, Logue G, Spaulding M (1991) Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies. Transfusion. 31 (7): 642–647

    Article  PubMed  CAS  Google Scholar 

  61. Imm A, Carlson RW (1993) Fluid resuscitation in circulatory shock. Crit Care Clin 9 (2): 313–333

    PubMed  CAS  Google Scholar 

  62. Ingram DA, Forman MB, Murray JJ (1993) Activation of complement by Fluosol attributable to the pluronic detergent micelle structure. J Cardiovasc Pharmacol 22 (3): 456–461

    Article  PubMed  CAS  Google Scholar 

  63. Iwashita Y, Yabuki A, Yamaji K, Iwasaki K, Okami T, Hirata C, Kosaka K (1988) A new resuscitation fluid »stabilized hemoglobin« preparation and characteristics. Biomat Art Cells Art Organs 16 (1–3): 271–280

    CAS  Google Scholar 

  64. Jones MM, Longmire S, Cotton DB, Dorman KF, Skjonsby BS, Joyce TH (1986) Influence of crystalloid versus colloid infusion on peripartum colloid osmotic pressure changes. Obstet Gynecol 68 (5): 659–661

    PubMed  CAS  Google Scholar 

  65. Jopski B, Pirkl V, Jaroni HW, Schubert R, Schmidt KH (1989) Preparation of hemoglobin-containing liposomes using octyl glucoside and octyltetraoxyethylene. Biochim Biophys Acta 978 (1): 79–84

    Article  PubMed  CAS  Google Scholar 

  66. Karanko MS (1988) Plasma volume substitution. Acta Anaesthesiol Scand Suppl 89: 54–57

    Article  CAS  Google Scholar 

  67. Keipert PE, Chang TM (1988) Pyridoxylated-polyhemoglobin solution. A low viscosity oxygen-delivering blood replacement fluid with normal oncotic pressure and longterm storage feasibility. Biomat Art Cells Art Organs 16 (13): 185–196

    CAS  Google Scholar 

  68. Kent KM, Cleman MW, Cowley MJ, Forman MB, Jaffe CC, Kaplan M, King SB, Krucoff MW, Lassar T, McAuley B et al. (1990) Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. Am J Cardiol 66: 279–284

    Article  PubMed  CAS  Google Scholar 

  69. Kerins DM (1994) Role of the perfluorocarbon Fluosol-DA in coronary angioplasty. Am J Med Sci 307: 218–221

    Article  PubMed  CAS  Google Scholar 

  70. Krafft MP, Postel M, Riess JG, Ni Y, Pelura TJ, Hanna GK, Song D (1992) Drop size stability assessment of fluorocarbon emulsions. J Biomat Art Cells Immobiliz Biotechnol 20 (2–4): 865–868

    CAS  Google Scholar 

  71. Kretschmer V, Weippert-Kretschmer M (1993) Autologous blood transfusion as whole blood or blood components? Beitr Infusionther 31: 209–214

    PubMed  CAS  Google Scholar 

  72. Labrude P (1992) Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions. Ann Pharm Fr 50 (5–6): 250–266

    PubMed  CAS  Google Scholar 

  73. Lane T, Smith D, Wancewicz E, Funk R (1993) Inhibition of endotoxin-mediated activation of endothelial cells by a per-fluorocarbon emulsion. Biomat Art Cells Immobiliz Biotechnol 21 (2): 163–172

    CAS  Google Scholar 

  74. Lenz G, Bissinger U (1994) Modifizierte Hämoglobinlösungen als künstliche Sauerstoffträger. Infusionsther Transfusionsmed 21 [Suppl 3]: 63–67

    PubMed  Google Scholar 

  75. Lenz G (1988) Pyridoxalierte Polyhämoglobinlösung als sauerstofftransportierendes Volumenersatzmittel. Tierexperimentelle Untersuchungen zu Hämodynamik, Sauerstofftransport and Organwirkungen. Enke, Stuttgart

    Google Scholar 

  76. Ljungstrom KG (1993) Safety of dextran in relation to other colloids ten years experience with hapten inhibition. Infusionsther Transfusionsmed 20 (5): 206–210

    PubMed  CAS  Google Scholar 

  77. Lowe KC (1991) Synthetic oxygen transport fluids based on perfluorochemicals: applications in medicine and biology. Vox Sang 60: 129–140

    Article  PubMed  CAS  Google Scholar 

  78. Lowe KC (1987) Perfluorocarbons as oxygen-transport fluids. Comp Biochem Physiol A 87 (4): 825–838

    Article  PubMed  CAS  Google Scholar 

  79. Lowe KC (1986) Blood transfusion or blood substitution? Vox Sang 51 (4): 257–263

    Article  PubMed  CAS  Google Scholar 

  80. Lowe KC, Bollands AD (1985) Physiological effects of perfluorocarbon blood substitutes. Med Lab Sci 42 (4): 367–375

    PubMed  CAS  Google Scholar 

  81. Lundsgaard-Hansen P, Tschirren B (1980) Die Verwendung von Plasmaersatzmitteln and Albumin im Rahmen der Komponententherapie. In: Ahnefeld FW, Bergmann H, Burri C, Dick W, Halmagyi M, Hossli G, Rügheimer E (eds) Klinische Anästhesiologie and Intensivtherapie. Springer, Heidelberg pp 120–135

    Google Scholar 

  82. Lutz H et al. (1986) Effects and side effects of colloid plasma substitutes as compared to albumin. Curr Stud Hematol Blood Transfus 53: 145–154

    PubMed  Google Scholar 

  83. Marelli TR (1994) Use of a hemoglobin substitute in the anemic Jehovah’s Witness patient. Crit Care Nurse 14: 31–38

    PubMed  CAS  Google Scholar 

  84. Martin SM, Laks H, Drinkwater DC, Stein DG, Capouya ER, Pearl JM, Barthel SW, Chang P, Kaczer E, Bhuta S (1993) Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia. Ann Thorac Surg 55 (4): 954960

    Google Scholar 

  85. Maxson AD, Giger U, Sweeney CR, Tomasic M, Saik JE, Donawick WJ, Cothran EG (1993) Use of a bovine hemoglobin preparation in the treatment of cyclic ovarian hemorrhage in a miniature horse. J Am Vet Med Assoc 203: 1308–1311

    PubMed  CAS  Google Scholar 

  86. Meinert H, Knoblich A (1993) The use of semifluorinates alkanes in blood substitutes. Biomat Art Cells Immobiliz Biotechnol 21 (5): 583–595

    CAS  Google Scholar 

  87. Meinert H, Reuter P, Mader J, Haidmann L, Northoff H (1992) Syntheses, interfacial active properties and toxicity of new perfluoralkylated surfactants. Biomat Art Cells Art Organs 20 (1): 115–124

    CAS  Google Scholar 

  88. Meinert H, Fackler R, Knoblich A, Mader J, Reuter P, Rohlke W (1992) On the perfluorocarbon emulsions of second generation. Biomat Art Cells Immobiliz Biotechnol 20 (2–4): 805–818

    CAS  Google Scholar 

  89. Menger MD, Thierjung C, Hammersen F, Messmer K (1993) Dextran vs. hydroxyethylstarch in inhibition of postischemic leukocyte adherence in striated muscle. Circ Shock 41: 248255

    Google Scholar 

  90. Mitsuno T, Ohyanagi H (1985) Present status of clinical studies of Fluosol-DA (20%) in Japan. Int Anesthesiol Clin 23: 169–184

    Article  PubMed  CAS  Google Scholar 

  91. Mitsuno T, Ohyanagi H, Naito R (1982) Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases. Ann Surg 195: 60–69

    Article  PubMed  CAS  Google Scholar 

  92. Mohan C, Gennaro M, Marini C, Ascer E (1992) Reduction of the extent of ischemic skeletal muscle necrosis by perfusion with oxygenated perfluorocarbon. Am J Surg 164 (3): 194–198

    Article  PubMed  CAS  Google Scholar 

  93. Nearman HS, Herman ML (1991) Toxic effects of colloids in the intensive care unit. Crit Care Clin 7 (3): 713–723

    PubMed  CAS  Google Scholar 

  94. Ning J, Chang TMS (1988) Effects of stroma-free Hb and polyhemoglobin on complement activation, blood cell counts and coagulation factors in rats. J Biomat Art Cells Immobiliz Biotechnol 16: 651–652

    Google Scholar 

  95. Nishi K, Ueda S, Sato D (1994) Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and stroma-free hemoglobin on renal vascular responsiveness to vasoactive substances in isolated perfused rat kidney. Art Organs 18: 429–438

    Article  CAS  Google Scholar 

  96. Northoff H, Markovic A, Schneider U (1994) Künstliche Sauerstoffträger–begrabene Hoffnung oder Medikamente mit Zukunftspotential? Dtsch Ärztebl 91 (Heft 46): 35–39

    Google Scholar 

  97. Odling-Smee W (1990) ABC of transfusion. Red cell substitutes. Bmj 300 (6724): 599–601

    Article  PubMed  CAS  Google Scholar 

  98. Ohyanagi H (1979) Fluosol DA 20 in human volunteers. Clin Therapeut 2: 306–312

    Google Scholar 

  99. Pockaj BA, Yang JC, Lotze MT, Lange JR, Spencer WF, Steinberg SM, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA (1994) A prospective randomizes trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy. J Immunother 15 (1): 22–28

    Article  CAS  Google Scholar 

  100. Police AM, Waxman K, Tominaga G (1985) Pulmonary complications after Fluosol administration to patients with life-threatening blood loss. Crit Care Med 13 (2): 96–98

    Article  PubMed  CAS  Google Scholar 

  101. Prouchayret F, Dellacherie E (1993) Low oxygen affinity derivatives of human hemoglobin by fixation of polycarboxylic dextran to the oxyform. Biopolymers 33 (12): 1803–1809

    Article  PubMed  CAS  Google Scholar 

  102. Rabiner SF, Helbert JR, Lopas H, Friedman LH (1967) Evaluation of a stroma-free hemoglobin solution for use as a plasma expander. J Exp Med 126: 1127–1142

    Article  PubMed  CAS  Google Scholar 

  103. Rackow EC, Mecher C, Astiz ME, Griffel M, Falk JL, Weil MH (1989) Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med 17: 394–398

    Article  PubMed  CAS  Google Scholar 

  104. Redl H, Krosl P, Schlag G, Hammerschmidt DE (1989) Permeability studies in a hypovolemic traumatic shock model: comparison of Ringer’s lactate and albumin as volume replacement fluids. Resuscitation 17 (1): 77–90

    Article  PubMed  CAS  Google Scholar 

  105. Reichelt H, Hoffmann G, Lederer S, Kretschmar K (1989) Veränderungen pathobiochemischer Reaktionen im traumatisch-hamorrhagischen Schock nach Therapie mit Blutersatzmitteln auf Perfluorcarbonbasis. (Changes in the pathobiochemical reactions in traumatic-hemorrhagic shock following therapy with blood substitutes based on perfluorcarbon). Z Med Lab Diagn 30 (1): 53–55

    PubMed  CAS  Google Scholar 

  106. Rentko VT (1992) Red blood cell substitutes. Probl Vet Med 4 (4): 647–651

    PubMed  CAS  Google Scholar 

  107. Riess JG, Krafft MP (1992) Elaboration of fluorocarbon emulsions with improved oxygen-carrying capabilities. Adv Exp Med Biol 317: 465–472

    Article  PubMed  CAS  Google Scholar 

  108. Riess JG, Dalfors JL, Hanna GK, Klein DH, Krafft MP, Pelura TJ, Schutt EG (1992) Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy. Biomat Art Cells Immobiliz Biotechnol 20: 839–842

    CAS  Google Scholar 

  109. Riess JG, Le Blanc M (1982) Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications. Pure Appl Chem 54: 2383–2406

    Article  CAS  Google Scholar 

  110. Rosen RL, Sehgal HL, Moss GS (1985) Transport of oxygen by perfluorochemical emulsions. Int Anesthesiol Clin 23 (1): 95103

    Article  Google Scholar 

  111. Rudolph AS, Cliff RO, Klipper R, Goins B, Phillips WT (1994) Circulation persistence and biodistribution of lyophilized liposome-encapsulatet hemoglobin: an oxygen-carrying resuscitative fluid. Crit Care Med 22 (1): 142–150

    PubMed  CAS  Google Scholar 

  112. Ruiz J, Danel V (1989) Volume expanders. Colloidal plasma substitutes. Soins 525: 53–56

    PubMed  Google Scholar 

  113. Saddler JM, Horsey PJ (1987) The new generation gelatins. A review of their history, manufacture and properties. Anaesthesia 42 (9): 998–1004

    Article  PubMed  CAS  Google Scholar 

  114. Salmon JB, Mythen MG (1993) Pharmacology and physiology of colloids. Blood Rev 7 (2): 114–120

    Article  PubMed  CAS  Google Scholar 

  115. Savitsky JP, Docziy J, Block J, Arnold JD (1978) A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 250: 73–80

    Google Scholar 

  116. Schott U, Lindbom LO, Sjostrand U (1988) Hemodynamic effects of colloid concentration in experimental hemorrhage: a comparison of Ringer’s acetate, 3% dextran-6o, and 6% dextran-70. Crit Care Med 16 (4): 346–352

    Article  PubMed  CAS  Google Scholar 

  117. Schönberger S (1992) Intraoperative Einflüsse von Hydroxyäthylstärke (zoo 000/0.5) 6% and Humanalbumin 5% auf Hämodynamik, Homöostase and Gerinnungsfunktion unter Blutkomponentensubstitution nach dem modifizierten Berner-Blutkomponentenschema nach Lundsgaard-Hansen. Diss, Univ Ulm

    Google Scholar 

  118. Schönfeld AH (1992) Tierexperimentelle Untersuchung zum Einfluß des Substitutionsgrades der Hydroxyethylstärke auf deren Pharmakokinetik and Pharmakodynamik. Diss, Univ Ulm

    Google Scholar 

  119. Sehgal LR, Sehgal HL, Rosen AL, Gould SA, DeWoskin R, Moss GS (1988) Characteristics of polymerized pyridoxylated hemoglobin. Biomat Art Cells Art Organs 16 (1–3): 173183

    Google Scholar 

  120. zo.Shoemaker S, Gerber M, Evans G, Paik L, Scoggin C (1993) Initial clinical experience with recombinant human hemoglobin (abstracts). Vth Int Symp Blood Substitutes, San Diego

    Google Scholar 

  121. Shoemaker WC (1986) Hemodynamic and oxygen transport effects of crystalloids and colloids in critically ill patients. Curr Stud Hematol Blood Transfus 53: 155–176

    PubMed  Google Scholar 

  122. Shoemaker WC, Hauser CJ (1979) Critique of cristalloid versus colloid therapy in shock and shock lung. Crit Care Med 7: 117–124

    Article  PubMed  CAS  Google Scholar 

  123. Sibbald WJ, Driedger AA, Wells GA, Myers ML, Lefcoe M (1983) The short-term effects of increasing plasma colloid osmotic pressure in patients with noncardiac pulmonary edema. Surgery 93: 620–633

    PubMed  CAS  Google Scholar 

  124. Sloviter HA (1985) Perfluorochemical emulsions and perfusions of isolated organs. Int Anesthesiol Clin 23 (1): 37–46

    Article  PubMed  CAS  Google Scholar 

  125. Smith DJ, Lane TA (1992) Effect of a high concentration per-fluorocarbon emulsion on platelet function. Biomat Art Cells Immobiliz Biotechnol 20 (2–4): 1045–1049

    CAS  Google Scholar 

  126. Staverman AJ (1951) The theory of measurement of osmotic pressure. Rec Tray Chim Pays Bas 70: 344–352

    Article  CAS  Google Scholar 

  127. Strecker U, Dick W, Madjidi A, Ant M (1993) The effect of the type of colloid on the efficacy of hypertonic saline colloid mixtures in hemorrhagic shock: dextran versus hydroxyethyl starch. Resuscitation 25 (1): 41–57

    Article  PubMed  CAS  Google Scholar 

  128. Takahashi H, Miyoshi T, Boki K (1993) Study on hydrophilic properties of gelatin as a clinical wound dressing. II. Water-absorbing property and hemostatic effect of gelatin. Tokushima J Exp Med 40: 169–175

    PubMed  CAS  Google Scholar 

  129. Tonnessen T, Tollofsrud S, Kongsgaard UE, Hoddeland H (1993) Colloid osmotic pressure of plasma replacement fluids. Acta Anaesthesiol Scand 37 (4): 424–426

    Article  PubMed  CAS  Google Scholar 

  130. Traverso LW, Hollenbach SJ, Bolin RB, Langford MJ, DeGuzman LR (1986) Fluid resuscitation after an otherwise fatal hemorrhage: II. Colloid solutions. J Traum 26 (2): 176–182

    Article  CAS  Google Scholar 

  131. Tremper KK, Andersson ST (1985) Perfluorochemical emulsion oxygen transport fluids: a clinical review. Annu Rev Med 36: 309–313

    Article  PubMed  CAS  Google Scholar 

  132. Tsuchida E, Komatsu T (1994) Synthetic hemes. Meth Enzymol 231: 167–93, 685

    Google Scholar 

  133. Velanovich V (1989) Crystalloid versus colloid fluids resuscitation. A meta-analysis of mortality. Surgery 105 (1): 65–71

    PubMed  CAS  Google Scholar 

  134. Vincent JL (1991) Plugging the leaks? New insights into synthetic colloids [editorial; comment]. Crit Care Med 19: 316–318

    Article  PubMed  CAS  Google Scholar 

  135. Vincent JL (1991) Fluids for reuscitation. Br J Anaesth 67 (2): 185–193

    Article  PubMed  CAS  Google Scholar 

  136. Vogel H, Gunther H, Harrison DK, Anderer W, Kessler M, Peter K (1989) Hemodilution and myocardial oxygen supply. The influence of fluosol-Da. Adv Exp Med Biol 248: 653–661

    Article  PubMed  CAS  Google Scholar 

  137. Vogel WM, Dennis RC, Cassidy G, Apstein CS, Valeri CR (1986) Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol 251: H413 - H420

    PubMed  CAS  Google Scholar 

  138. Vogt N et al. (1994) Comparison of 5% human albumin and 6% 200/0.5 HES as exclusive colloid components in large surgical interventions. Anasthesiol Intensivmed Notfallmed Schmerzther 29: 150–156

    Article  PubMed  CAS  Google Scholar 

  139. Von Bormann B, Friedrich M (1993) Hämodilution (Hamodilution). Klin Anaethesiol Intensivther 43: 161–171

    Article  Google Scholar 

  140. Von Bormann B, Friedrich M (1993) Indikationen and Kontraindikationen von Hamodilution (Indications and contraindications of hemodilution). Beitr Infusionsther 29: 97–117

    Google Scholar 

  141. Von Bormann B, Aulich S, Klein R (1993) Volumentherapie in der operativen Medizin. Krankenhaus Arzt 66: 44–51

    Google Scholar 

  142. Walder RY, Andracki ME, Walder JA (1994) Preparation of intramolecularly cross-linked hemoglobins. Meth Enzymol 231: 274–280

    Article  PubMed  CAS  Google Scholar 

  143. Wall TC, Calif RM, Blankenship J, Talley JD, Tannenbaum M, Schwaiger M, Gacioch G, Cohen MD, Sanz M, Leimberger JD et al. (1994) Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group. Circulation 90: 114–120

    Article  PubMed  CAS  Google Scholar 

  144. Waschke K, Krieter H, Albrecht DM, van Ackern K, Kuschinsky W (1993) Modified hemoglobin as a blood substitute in a rat model. Anaesthesist 42: 90–95

    PubMed  CAS  Google Scholar 

  145. Watanabe M (1992) Use of Fluosol-DA for rescue of Jehovah’s witnesses patients. In: Frey R, Beisbarth H, Stosseck K (eds) Oxygen carrying colloidal blood substitutes. Zuckschwerdt, München

    Google Scholar 

  146. Waters LM, Christensen MA, Sato RM (1989) Hetastarch: an alternative colloid in burn shock management. Division of Plastic and Reconstructive Surgery University Medical Center, CA 94305 10 (1): 11–16

    Google Scholar 

  147. Waxman K, Tremper KK, Mason GR (1985) Blood and plasma substitutes-plasma expansion and oxygen transport properties. West J Med 143 (2): 202–206

    PubMed  CAS  Google Scholar 

  148. Webb AR, Barclay SA, Bennett ED (1989) In vitro colloid osmotic pressure of commonly used plasma expanders and substitutes: a study of the diffusibility of colloid molecules. Int Care Med 15 (2): 116–120

    Article  CAS  Google Scholar 

  149. Weigand K (1980) Synthese, Verteilung und Bedeutung von Serumalbumin. In: Ahnefeld FW, Bergmann H, Burri C, Dick W, Halmagyi M, Hossli G, Rügheimer E (Hrsg) Klinische Anästhesiologie und Intensivtherapie. Springer, Heidelberg S 52–64

    Google Scholar 

  150. Weigand MAM (1992) Tierexperimentelle Untersuchung zum Einfluß des Molekulargewichtes der Hydroxyethylstärke auf deren Pharmakokinetik und Pharmakodynamik. Diss, Univ Ulm

    Google Scholar 

  151. Winslow RM (1994) Vasoconstriction and the efficacy of hemoglobin-based blood substitutes. Transfus Clin Biol 1: 9–14

    Article  PubMed  CAS  Google Scholar 

  152. Xue H, Wong JT (1994) Preparation of conjugated hemoglobins. Meth Enzymol 231: 308–322

    Article  PubMed  CAS  Google Scholar 

  153. Zadrobilek E, Hackl W, Sporn P, Steinbereithner K (1989) Effect of large volume replacement with crystalloids on extra-vascular lung water in human septic shock syndrome. Prog Clin Biol Res 308: 809–813

    PubMed  CAS  Google Scholar 

  154. Zheng S, Zheng Y, Beissinger RL, Wasan DT, McCormick DL (1993) Hemoglobin multiple emulsion as an oxygen delivery system. Biochim Biophys Acta 1158 (1): 65–74

    Article  PubMed  CAS  Google Scholar 

  155. Zikria BA, King TC, Stanford J, Freeman HP (1989) A biophysical approach to capillary permeability. Surgery 105: 625–631

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Grünert
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Klinische Immunologie und Transfusionsmedizin der Universität, Langhansstr. 7, D-35385, Gießen, Deutschland

    Christian Mueller-Eckhardt

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Grünert, A. (1996). Blutersatzstoffe. In: Mueller-Eckhardt, C. (eds) Transfusionsmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10599-3_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10599-3_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10600-6

  • Online ISBN: 978-3-662-10599-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation